Exclusive: Gilead says open to collaborate with govts, drug cos to make Remdesivir globally available

There is a possibility of Indian cos becoming part of the consortium, in the past Gilead used voluntary licenses to rope in Indian cos to manufacture and launch HIV and hepatitis-C medications in low-middle-income countries (LMICs).